Gsa Capital Partners LLP Incyte Corp Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

A detailed history of Gsa Capital Partners LLP transactions in Incyte Corp stock. As of the latest transaction made, Gsa Capital Partners LLP holds 6,453 shares of INCY stock, worth $501,591. This represents 0.03% of its overall portfolio holdings.

Number of Shares

6,453

Previous 5,102 26.48%

Holding current value

$501,591

Previous $309,000 38.19%

% of portfolio

0.03%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$57.33 - $68.61 $77,452 - $92,692	1,351 Added 26.48%	6,453 $427,000
Q2 2024 Aug 15, 2024	SELL	$51.18 - $63.75 $764,782 - $952,616	-14,943 Reduced 74.55%	5,102 $309,000
Q1 2024 May 03, 2024	SELL	$56.55 - $66.59 $373,965 - $440,359	-6,613 Reduced 24.81%	20,045 $1.14 Million
Q4 2023 Feb 16, 2024	SELL	$52.16 - $64.19 $652,625 - $803,145	-12,512 Reduced 31.94%	26,658 $1.67 Million
Q3 2023 Nov 15, 2023	BUY	$57.77 - $65.93 $1.9 Million - $2.16 Million	32,822 Added 517.04%	39,170 $2.26 Million
Q2 2023 Aug 14, 2023	BUY	$60.95 - $75.51 $51,990 - $64,410	853 Added 15.52%	6,348 $395,000
Q1 2023 May 12, 2023	BUY	$70.23 - $86.01 $385,913 - $472,624	5,495 New	5,495 $397,000
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $137,985 - $172,763	2,085 Added 67.85%	5,158 $344,000
Q2 2022 Aug 09, 2022	BUY	$66.18 - $83.18 $203,371 - $255,612	3,073 New	3,073 $233,000
Q1 2022 May 11, 2022	SELL	$66.02 - $79.71 $303,163 - $366,028	-4,592 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $82,595 - $96,639	-1,304 Reduced 22.12%	4,592 $337,000
Q3 2021 Nov 12, 2021	BUY	$68.67 - $84.02 $404,878 - $495,381	5,896 New	5,896 $406,000
Q4 2020 Feb 03, 2021	SELL	$80.74 - $97.7 $245,772 - $297,398	-3,044 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$85.07 - $109.69 $258,953 - $333,896	3,044 New	3,044 $273,000
Q1 2020 May 12, 2020	SELL	$63.18 - $85.97 $1.02 Million - $1.39 Million	-16,116 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$73.04 - $95.72 $17,310 - $22,685	237 Added 1.49%	16,116 $1.41 Million
Q3 2019 Nov 12, 2019	BUY	$72.82 - $86.52 $306,280 - $363,903	4,206 Added 36.03%	15,879 $1.18 Million
Q2 2019 Aug 06, 2019	SELL	$73.52 - $88.7 $176,889 - $213,412	-2,406 Reduced 17.09%	11,673 $992,000
Q1 2019 May 15, 2019	SELL	$63.56 - $88.17 $45,445 - $63,041	-715 Reduced 4.83%	14,079 $1.21 Million
Q4 2018 Feb 12, 2019	SELL	$58.5 - $69.94 $743,535 - $888,937	-12,710 Reduced 46.21%	14,794 $941,000
Q3 2018 Nov 13, 2018	BUY	$61.75 - $74.23 $792,067 - $952,148	12,827 Added 87.4%	27,504 $1.9 Million
Q2 2018 Aug 09, 2018	BUY	$60.85 - $83.98 $671,723 - $927,055	11,039 Added 303.44%	14,677 $983,000
Q1 2018 May 11, 2018	BUY	$83.06 - $100.98 $33,805 - $41,098	407 Added 12.6%	3,638 $303,000
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $2.02 Million - $2.52 Million	-21,626 Reduced 87.0%	3,231 $306,000
Q3 2017 Nov 20, 2017	BUY	$109.15 - $138.27 $2.71 Million - $3.44 Million	24,857	24,857 $2.9 Million

Others Institutions Holding INCY

# of Institutions

640

Shares Held

187M

Call Options Held

729K

Put Options Held

479K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $17.3B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Incyte Corp Transaction History